ARTICLE | Company News
ImmuLogic Pharmaceuticals Corp. other research news
January 10, 1994 8:00 AM UTC
IMUL (Waltham, Mass.) said it completed its Phase II Allervax Cat catroom challenge study. The company said the overall safety profile was comparable to the Phase I study and that preliminary analysis...